Prognostic and Predictive Biomarkers

While prognostic biomarkers hint at the likely outcome of a patient with a particular disease regardless of their treatment, predictive biomarkers provide information on whether that patient will respond to a certain agent. Some markers provide both of these functions. For instance, estrogen receptor positivity in breast cancer patients indicates a favorable prognosis (providing prognostic information); at the same time, it means that the patient will probably respond to endocrine therapy.

 

  • Prognostic Biomarkers: Analysis of Mutations and Polymorphisms
  • Prognostic Biomarkers: Analysis of Gene and MicroRNA
  • Predictive Biomarkers: Analysis of Mutations and Polymorphisms
  • Predictive Biomarkers: Analysis of Gene and MicroRNA

Related Conference of Prognostic and Predictive Biomarkers

October 04-05, 2023

8th Global Summit on Cancer Science and Oncology

Barcelona, Spain
November 08-09, 2023

International Conference on Cancer Biology and Therapeutics

Budapest, Hungary
November 15-16, 2023

36th Conference on Preventive Oncology and Diagnostic Cancer

Edinburgh, Scotland
December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE

Prognostic and Predictive Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in